Class II · Moderate risk
Simvastatin
cGMP deviations
FDA Drug Recalls
11,818 recalls · Class II, newest first
Class II · Moderate risk
Glimepiride
cGMP deviations
Class II · Moderate risk
Glimepiride
cGMP deviations
Class II · Moderate risk
Glimepiride
cGMP deviations
Class II · Moderate risk
Ropinirole
cGMP deviations
Class II · Moderate risk
Ropinirole
cGMP deviations
Class II · Moderate risk
Finasteride
cGMP deviations
Class II · Moderate risk
Montelukast Sodium Tablets
cGMP deviations
Class II · Moderate risk
JARDIANCE (Empagliflozin)
Labeling: Label Mix-up
Class II · Moderate risk
Calcitonin Salmon Nasal Spray
Failed Impurities/Degradation Specifications and Subpotent Drug: High Out of Specification results for a known and unknown impurity as well as low Out of Specification results for assay.
Class II · Moderate risk
Clobazam Tablets
CGMP Deviations: Potential risk of Cross Contamination
Class II · Moderate risk
Clobazam Tablets
CGMP Deviations: Potential risk of Cross Contamination
Class II · Moderate risk
Alprazolam Tablets
CGMP Deviations: Potential risk of Cross Contamination
Class II · Moderate risk
Alprazolam Tablets
CGMP Deviations: Potential risk of Cross Contamination
Class II · Moderate risk
Alprazolam Tablets
CGMP Deviations: Potential risk of Cross Contamination
Class II · Moderate risk
Alprazolam Tablets
CGMP Deviations: Potential risk of Cross Contamination
Class II · Moderate risk
Heparin Sodium
Subpotent Drug: low Anti-Factor IIa potency.
Class II · Moderate risk
Heparin Sodium Injection
Labeling: Not elsewhere classified
Class II · Moderate risk
Class II · Moderate risk
Activator Concentrate
CGMP DEVIATIONS
Class II · Moderate risk
Nose Better Gel
CGMP DEVIATIONS
Class II · Moderate risk
Soltice Quick-RUB
CGMP DEVIATIONS
Class II · Moderate risk
Unguentine Original Ointment for Burns
CGMP DEVIATIONS
Class II · Moderate risk
Vencedor medicated balm
CGMP DEVIATIONS
Class II · Moderate risk
Alcolado Relampago
CGMP DEVIATIONS